Home				Neurodegenerative Diseases Tx/Dx CI - Y2006 week 43
DATE	SOURCE	OTHER PARTY INVOLVED	INDICATION(S)	HEADLINES - CLICK TO VIEW FULL RELEASE
10/25/06	Elan (IR)		Various	Elan Reports Third Quarter 2006 Financial Results
10/24/06	Cortex Pharmaceuticals (US)		Various	Cortex to Hold Conference Call on October 26 Following Release of CX717 from FDA Clinical Hold
10/23/06	Berlex (US)	Schering (DE)	Multiple sclerosis	FDA Approves Betaseron(R) for Use After the First Event Suggestive of Multiple Sclerosis
10/23/06	Schering (DE)	Berlex (US)	Multiple sclerosis	Betaseron approved in the U.S. for earliest stages of Multiple Sclerosis